Expansion Plans of Kamel Ghribi in Healthcare

Kamel Ghribi, an international investment executive known for leading one of Europe’s largest private healthcare networks, is optimistic about the potential for collaboration with the United States in various areas like medical technology, hospital development, and research. His organization has ambitious plans for international growth aimed at the year 2030.

During a recent interview in New York coinciding with the United Nations General Assembly, Ghribi, who serves as the president of GKSD Investment Holding and vice president of Italy’s Gruppo San Donato, shared insights into his aspirations. He hosted a summit focused on economic development and healthcare cooperation during this time.

Ghribi noted that the U.S. represents a significant opportunity. He highlighted the strong ties between the U.S. and Italy and expressed interest in further engaging with American companies and healthcare institutions.

“Italy and the U.S. are really, really close,” he said. “We have great relationships. We look forward to doing more with the U.S.”

His ambitions include assessing the American hospital market. However, he clarified that his organization is still in the process of identifying suitable locations.

“We are studying the markets, places like Texas, places like Florida, places like California,” he mentioned. “So we are right now mapping the markets to see where the opportunities are.”

Ghribi also sees potential for collaboration with U.S. firms and research institutions, aiming to leverage advanced medical technologies for healthcare markets in developing countries.

“There’s a great desire to do more with the U.S. for our group,” he stated. “We see opportunities in the United States. We see opportunities in Africa with the United States involved with technology.”

The objective, according to Ghribi, is to merge the organization’s medical know-how with American technological strengths to enhance access to specialized health care while creating economic and social benefits.

His network, which is extensive, includes around 161 facilities, over 11,000 physicians, and services benefiting nearly 6.5 million patients. Gruppo San Donato stands as Italy’s largest private hospital group, providing a blend of patient care, medical education, and research with an expanding international reach into regions like Poland, the Middle East, and Africa.

One of their prominent facilities is Milan’s San Raffaele Hospital, a well-known center for specialized medical services, scientific study, and physician training, particularly in areas like regenerative medicine and robotic surgery.

The network uses advanced techniques, like three-dimensional anatomical models, to assist surgeons in preparing for complicated surgeries, including pediatric cardiac procedures, and is also exploring AI technologies to restore lost neurological functions.

When asked what sets his organization apart in healthcare, Ghribi provided a memorable analogy: “I would say it’s the Rolls-Royce of health care.”

He explained that their model encompasses more than hospital operations; it includes physician education and specialized technologies designed to elevate care quality while ensuring consistency as they grow.

Looking ahead to 2030, Ghribi expressed a desire to expand the group’s international footprint while developing new capabilities in precision medicine, regenerative treatments, and AI-enhanced healthcare.

“Our vision for 2030 really is to now expand our borders, our coverage,” he articulated, identifying markets like Albania, Kenya, Iraq, Libya, and the U.S. as key players in the group’s global strategy.

He emphasized that growth must be cautious and accompanied by necessary investments in medical professionals and technology to maintain high treatment standards.

“We have to do this expansion in a very controlled manner because quality is key,” he cautioned.

Ghribi mentioned that AI is playing a growing role in their research efforts, including collaborations with companies like Microsoft on medical applications, as well as early discussions with Google for potential partnerships.

However, he also warned about the risks of incorporating new technology in healthcare, where unregulated systems can pose serious threats to patient safety.

“AI is all great, but it comes with risks,” he noted, stressing the importance of rigorous testing before implementing any new medical technology. “Ethics is key,” he added, remarking on the potential dangers of mishandled data.

Ghribi’s commitment to international partnerships is also reflected in his founding of the European Corporate Council on Africa and the Middle East (ECAM), a nonprofit aimed at fostering economic cooperation across these regions.

On September 24, he organized the eighth ECAM Council Summit at The Plaza Hotel in New York, which brought together notable leaders like Kenyan President William Ruto and Italian Foreign Minister Antonio Tajani.

The summit highlighted the unveiling of the ECAM Charter on Africa, a framework designed to promote African ownership and sustainable economic development.

At the event, Ghribi emphasized that Africa does not need charity; rather, it requires partnerships. “Africa does not need charity; it needs partners,” he stated. “Africa is not the continent of tomorrow. It is the continent of today.”

In his conversation with the press, Ghribi elaborated that combining American and European expertise with Middle Eastern investments and African involvement could significantly accelerate development across Africa.

He noted that enhancing healthcare infrastructure in Africa could result in broader benefits, such as job creation, local professional training, and stimulating economic activity in historically underserved communities.

Such investments, he argued, could also mitigate illegal immigration by enabling individuals to foster opportunities within their communities rather than seeking them elsewhere.

“We want to create economic value with the Africans being a part of it,” he said. “It will tackle the problem of illegal immigration.”

Ghribi believes that aligning with U.S. and European companies can maximize their efforts. “We feel that with the U.S. alignment, the U.S. companies or European companies, together we can do much more, accelerate the pace,” he remarked.

A recent initiative involves a proposed $419 million investment for 15 hospitals in Kenya, which Ghribi announced in September through an agreement with the country’s Ministry of Health. His organization is evaluating how its expertise in design and engineering can be brought to these projects.

Additionally, they have launched hospital management operations in Iraq, particularly in Basra and Najaf, expanding specialized treatments and pediatric cardiac care. In Libya, they have taken over a hospital’s operations in Benghazi and are seeking other opportunities in Tripoli.

Ghribi has maintained connections with American political circles and received a Global Leadership Award recently during celebrations of America’s 250th independence anniversary. He also participated in presenting a global health leadership award at a gathering in New York.

More recently, he was present at President Donald Trump’s Columbus Day celebration at the White House.

Ezra Friedlander, a notable figure from Project Legacy, commended Ghribi’s dedication to fostering international cooperation through healthcare investments, asserting that closer ties with him could yield significant benefits for the U.S.

“The United States should fully embrace and engage with Kamel Ghribi’s leadership,” Friedlander remarked, highlighting his extensive network as a potential gateway to increased prosperity and stability.

Ultimately, Ghribi’s vision extends beyond merely increasing hospital numbers or market presence. He is focused on merging medical expertise, technological advancements, and international investments to transform healthcare accessibility.

“We totally respect the intellectual capital in the U.S.,” he said, confident in the potential for enhanced healthcare cooperation both domestically and on a global scale.

“But also together, we can go across so many borders,” he continued, emphasizing that access to quality healthcare should transcend national boundaries. “Everybody should have good quality health care.”